tradingkey.logo
tradingkey.logo
Search

Quanterix Corp

QTRX
Add to Watchlist
2.750USD
-0.020-0.72%
Close 05/15, 16:00ETQuotes delayed by 15 min
129.54MMarket Cap
LossP/E TTM

Quanterix Corp

2.750
-0.020-0.72%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Quanterix Corp

Currency: USD Updated: 2026-05-15

Key Insights

Quanterix Corp's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 75 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 4.33.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Quanterix Corp's Score

Industry at a Glance

Industry Ranking
75 / 206
Overall Ranking
187 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Quanterix Corp Highlights

StrengthsRisks
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 138.90M.
Overvalued
The company’s latest PE is -1.17, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 42.63M shares, decreasing 10.46% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 104.77K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.05.

Analyst Rating

Based on 3 analysts
Hold
Current Rating
4.333
Target Price
+56.44%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of Quanterix Corp is 6.87, ranking 104 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 36.41M, representing a year-over-year increase of 20.05%, while its net profit experienced a year-over-year increase of 14.45%.

Score

Industry at a Glance

Previous score
6.87
Change
0

Financials

6.68

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

7.19

Operational Efficiency

5.26

Growth Potential

7.96

Shareholder Returns

7.23

Quanterix Corp's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of Quanterix Corp is 8.67, ranking 14 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -1.17, which is 0.00% below the recent high of -1.17 and -3113.27% above the recent low of -37.50.

Score

Industry at a Glance

Previous score
8.67
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 75/206
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

The current earnings forecast score of Quanterix Corp is 6.00, ranking 175 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 6.50, with a high of 8.00 and a low of 5.00.

Score

Industry at a Glance

Previous score
6.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts
Hold
Current Rating
4.333
Target Price
+56.44%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Quanterix Corp
QTRX
3
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
35
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
19

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of Quanterix Corp is 5.63, ranking 172 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 3.37 and the support level at 2.34, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
5.73
Change
-0.1

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.005
Neutral
RSI(14)
34.084
Neutral
STOCH(KDJ)(9,3,3)
22.067
Neutral
ATR(14)
0.304
High Vlolatility
CCI(14)
-82.128
Neutral
Williams %R
81.553
Oversold
TRIX(12,20)
-0.941
Sell
StochRSI(14)
13.800
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
2.822
Sell
MA10
2.965
Sell
MA20
3.100
Sell
MA50
3.646
Sell
MA100
5.055
Sell
MA200
5.361
Sell

Institutional Confidence

Currency: USD Updated: 2026-05-15

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Portolan Capital Management, L.L.C.
4.26M
+17.23%
Columbia Threadneedle Investments (UK)
3.14M
+0.28%
BlackRock Institutional Trust Company, N.A.
2.86M
+8.01%
Telegraph Hill Partners
2.50M
--
Blue Water Life Science Advisors, LP.
957.75K
--
William Blair Investment Management, LLC
1.32M
+16.60%
Walt (David R)
1.86M
+0.14%
Columbia Threadneedle Investments (US)
1.11M
-0.19%
Invenomic Capital Management LP
1.39M
+21.67%
1
2

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Quanterix Corp is 4.92, ranking 92 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.13. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
4.92
Change
0
Beta vs S&P 500 index
1.11
VaR
+6.92%
240-Day Maximum Drawdown
+65.88%
240-Day Volatility
+80.52%

Return

Best Daily Return
60 days
+10.35%
120 days
+23.81%
5 years
+33.66%
Worst Daily Return
60 days
-16.41%
120 days
-16.41%
5 years
-54.76%
Sharpe Ratio
60 days
-3.77
120 days
-1.67
5 years
-0.37

Risk Assessment

Maximum Drawdown
240 days
+65.88%
3 years
+90.40%
5 years
+95.22%
Return-to-Drawdown Ratio
240 days
-0.72
3 years
-0.32
5 years
-0.20
Skewness
240 days
+1.29
3 years
+0.35
5 years
-0.30

Volatility

Realised Volatility
240 days
+80.52%
5 years
+81.41%
Standardised True Range
240 days
+14.13%
5 years
+41.40%
Downside Risk-Adjusted Return
120 days
-274.08%
240 days
-274.08%
Maximum Daily Upside Volatility
60 days
+53.03%
Maximum Daily Downside Volatility
60 days
+65.31%

Liquidity

Average Turnover Rate
60 days
+2.64%
120 days
+2.23%
5 years
--
Turnover Deviation
20 days
+107.20%
60 days
+51.99%
120 days
+28.39%

Peer Comparison

Healthcare Equipment & Supplies
Quanterix Corp
Quanterix Corp
QTRX
6.84 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI